The foundations of pharmaceutical
biotechnology mainly lie in the capability of plants, microorganism and animals
to produce low and high molecular weight compounds useful as therapeutics.
Although molecules from plants and
microorganisms are preferred extraction from plant biomass needs tedious
downstream processing while in case of microorganisms it is easy with fewer
amounts of impurities. Pharmaceutical biotechnology is poised to
flourish for the last 4-6 decades with the advent of recombinant DNA technology
and metabolic engineering supported by the well-developed bioprocess
technology.
Large scale production and cost effectiveness
and affordability could be achieved by way of synergising all these
technologies.
